156 related articles for article (PubMed ID: 9243140)
1. Evolution of coronary atherosclerosis in patients with mild coronary artery disease studied by serial quantitative coronary angiography at 2 and 4 years follow-up. The Multicenter Anti-Atheroma Study (MAAS) Investigators.
Vos J; de Feyter PJ; Kingma JH; Emanuelsson H; Legrand V; Winkelmann B; Dumont JM; Simoons LM
Eur Heart J; 1997 Jul; 18(7):1081-9. PubMed ID: 9243140
[TBL] [Abstract][Full Text] [Related]
2. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS).
Lancet; 1994 Sep; 344(8923):633-8. PubMed ID: 7864934
[TBL] [Abstract][Full Text] [Related]
3. Intravascular ultrasound study of angiographically mildly diseased coronary arteries.
Porter TR; Sears T; Xie F; Michels A; Mata J; Welsh D; Shurmur S
J Am Coll Cardiol; 1993 Dec; 22(7):1858-65. PubMed ID: 8245340
[TBL] [Abstract][Full Text] [Related]
4. Serial quantitative coronary angiography and coronary events.
Mack WJ; Xiang M; Selzer RH; Hodis HN
Am Heart J; 2000 Jun; 139(6):993-9. PubMed ID: 10827379
[TBL] [Abstract][Full Text] [Related]
5. Diabetes Atherosclerosis Intervention Study (DAIS): quantitative coronary angiographic analysis of coronary artery atherosclerosis.
McLaughlin PR; Gladstone P
Cathet Cardiovasc Diagn; 1998 Jul; 44(3):249-56. PubMed ID: 9676791
[TBL] [Abstract][Full Text] [Related]
6. Association of progression or regression of coronary artery atherosclerosis with long-term prognosis.
Ndrepepa G; Iijima R; Kufner S; Braun S; Cassese S; Byrne RA; Sorges J; Schulz-Schüpke S; Hoppmann P; Fussaro M; Laugwitz KL; Schunkert H; Kastrati A
Am Heart J; 2016 Jul; 177():9-16. PubMed ID: 27297844
[TBL] [Abstract][Full Text] [Related]
7. Progression of coronary artery disease is dependent on anatomic location and diameter. The INTACT investigators.
Jost S; Deckers JW; Nikutta P; Rafflenbeul W; Wiese B; Hecker H; Lippolt P; Lichtlen PR
J Am Coll Cardiol; 1993 May; 21(6):1339-46. PubMed ID: 8473639
[TBL] [Abstract][Full Text] [Related]
8. Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The Harvard Atherosclerosis Reversibility Project Study Group.
Stone PH; Gibson CM; Pasternak RC; McManus K; Diaz L; Boucher T; Spears R; Sandor T; Rosner B; Sacks FM
Am J Cardiol; 1993 Apr; 71(10):766-72. PubMed ID: 8456751
[TBL] [Abstract][Full Text] [Related]
9. Evolution of coronary stenoses is related to baseline severity--a prospective quantitative angiographic analysis in patients with moderate coronary disease. INTACT Investigators. International Nifedipine Trial on Antiatherosclerotic Therapy.
Jost S; Deckers JW; Nikutta P; Wiese B; Rafflenbeul W; Hecker H; Lippolt P; Lichtlen PR
Eur Heart J; 1994 May; 15(5):648-53. PubMed ID: 8056005
[TBL] [Abstract][Full Text] [Related]
10. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments.
Yamagishi M; Miyatake K; Tamai J; Nakatani S; Koyama J; Nissen SE
J Am Coll Cardiol; 1994 Feb; 23(2):352-7. PubMed ID: 8294686
[TBL] [Abstract][Full Text] [Related]
11. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study.
Sipahi I; Tuzcu EM; Moon KW; Nicholls SJ; Schoenhagen P; Zhitnik J; Crowe TD; Kapadia S; Nissen SE
Heart; 2008 May; 94(5):623-7. PubMed ID: 18070944
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial.
Sipahi I; Tuzcu EM; Schoenhagen P; Nicholls SJ; Chen MS; Crowe T; Loyd AB; Kapadia S; Nissen SE
Atherosclerosis; 2006 Nov; 189(1):229-35. PubMed ID: 16427643
[TBL] [Abstract][Full Text] [Related]
13. Secondary preventive potential of lipid-lowering drugs. The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
de Faire U; Ericsson CG; Grip L; Nilsson J; Svane B; Hamsten A
Eur Heart J; 1996 Dec; 17 Suppl F():37-42. PubMed ID: 8960446
[TBL] [Abstract][Full Text] [Related]
14. Quantitative angiographic follow-up studies on the development of coronary artery disease: which coronary segments should be analyzed? Experience from INTACT.
Jost S; Deckers J; Rafflenbeul W; Reiber JH; Nikutta P; Wiese B; Hecker H; Lippolt P; Riedel M; Nolte CW
Int J Card Imaging; 1993 Mar; 9(1):29-37. PubMed ID: 8491998
[TBL] [Abstract][Full Text] [Related]
15. Validation by high-frequency epicardial echocardiography of a new method of analyzing coronary angiography quantitatively in coronary artery disease.
McPherson DD; Johnson MR; Collins SM; Kieso RA; Marcus ML; Kerber RE
Am J Cardiol; 1993 Jan; 71(1):28-32. PubMed ID: 8420232
[TBL] [Abstract][Full Text] [Related]
16. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.
Ballantyne CM; Raichlen JS; Nicholls SJ; Erbel R; Tardif JC; Brener SJ; Cain VA; Nissen SE;
Circulation; 2008 May; 117(19):2458-66. PubMed ID: 18378607
[TBL] [Abstract][Full Text] [Related]
17. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
18. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T
J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514
[TBL] [Abstract][Full Text] [Related]
19. Natural history of coronary atherosclerosis by multislice computed tomography.
Papadopoulou SL; Neefjes LA; Garcia-Garcia HM; Flu WJ; Rossi A; Dharampal AS; Kitslaar PH; Mollet NR; Veldhof S; Nieman K; Stone GW; Serruys PW; Krestin GP; de Feyter PJ
JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S28-37. PubMed ID: 22421228
[TBL] [Abstract][Full Text] [Related]
20. Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT).
Kleemann A; Eckert S; von Eckardstein A; Lepper W; Schernikau U; Gleichmann U; Hanrath P; Fleck E; Neiss A; Kerber S; Assmann G; Breithardt G;
Eur Heart J; 1999 Oct; 20(19):1393-406. PubMed ID: 10487800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
